BACKGROUND: The presence of microvascular obstruction (MVO) is associated with more severely impaired left ventricular function and adverse prognosis. The aim of this study was to evaluate whether a single cardiac troponin T-value (cTnT) was able to predict the presence of MVO and whether cTnT is an independent predictor of MVO as compared to usual risk factors. STUDY DESIGN AND METHODS: Sixty-one consecutive patients with reperfused ST-elevation myocardial infarction (STEMI) were enrolled in the study. cTnT was measured serially at admission and after 24, 48, 72 and 96 h. Contrast-enhanced cardiac magnetic resonance imaging (CE-MRI) was performed on a 1.5T MR-scanner 4 +/- 1 days after STEMI. RESULTS: cTnT-time concentration kinetics in the presence of MVO differs from cTnT release in the absence of MVO showing a higher peak and a slower release. At single point measurement 24 h-cTnT correlates at least as well with the presence of MVO (P < 0.001) as peak cTnT (P = 0.0016) and sampling over 96 h (P < 0.001). Using ROC analysis, at single measurement a cTnT concentration >2.52 microg/l at 24 h was a predictor for MVO (AUC 0.91) with a sensitivity of 100% and a specificity of 80% with a positive predictive value of 76% and a negative predictive value of 100%. In multivariate regression analysis 24 h-cTnT remained independent predictor for MVO. CONCLUSIONS: In STEMI, a single 24 h-cTnT value is an independent predictor for MVO and a convenient and inexpensive way to help define this important risk parameter in clinically routine.
BACKGROUND: The presence of microvascular obstruction (MVO) is associated with more severely impaired left ventricular function and adverse prognosis. The aim of this study was to evaluate whether a single cardiac troponin T-value (cTnT) was able to predict the presence of MVO and whether cTnT is an independent predictor of MVO as compared to usual risk factors. STUDY DESIGN AND METHODS: Sixty-one consecutive patients with reperfused ST-elevation myocardial infarction (STEMI) were enrolled in the study. cTnT was measured serially at admission and after 24, 48, 72 and 96 h. Contrast-enhanced cardiac magnetic resonance imaging (CE-MRI) was performed on a 1.5T MR-scanner 4 +/- 1 days after STEMI. RESULTS:cTnT-time concentration kinetics in the presence of MVO differs from cTnT release in the absence of MVO showing a higher peak and a slower release. At single point measurement 24 h-cTnT correlates at least as well with the presence of MVO (P < 0.001) as peak cTnT (P = 0.0016) and sampling over 96 h (P < 0.001). Using ROC analysis, at single measurement a cTnT concentration >2.52 microg/l at 24 h was a predictor for MVO (AUC 0.91) with a sensitivity of 100% and a specificity of 80% with a positive predictive value of 76% and a negative predictive value of 100%. In multivariate regression analysis 24 h-cTnT remained independent predictor for MVO. CONCLUSIONS: In STEMI, a single 24 h-cTnT value is an independent predictor for MVO and a convenient and inexpensive way to help define this important risk parameter in clinically routine.
Authors: Tomasz Rakowski; Jaroslaw Zalewski; Jacek Legutko; Stanislaw Bartus; Lukasz Rzeszutko; Artur Dziewierz; Danuta Sorysz; Leszek Bryniarski; Krzysztof Zmudka; Grzegorz L Kaluza; Jacek S Dubiel; Dariusz Dudek Journal: Am Heart J Date: 2007-03 Impact factor: 4.749
Authors: Tareq Ibrahim; Hubertus P Bülow; Thomas Hackl; Mira Hörnke; Stephan G Nekolla; Martin Breuer; Albert Schömig; Markus Schwaiger Journal: J Am Coll Cardiol Date: 2006-12-29 Impact factor: 24.094
Authors: K C Wu; R J Kim; D A Bluemke; C E Rochitte; E A Zerhouni; L C Becker; J A Lima Journal: J Am Coll Cardiol Date: 1998-11-15 Impact factor: 24.094
Authors: John F Younger; Sven Plein; Julian Barth; John P Ridgway; Stephen G Ball; John P Greenwood Journal: Heart Date: 2007-05-31 Impact factor: 5.994
Authors: Christoph J Jensen; Holger C Eberle; Kai Nassenstein; Thomas Schlosser; Mani Farazandeh; Christoph K Naber; Georg V Sabin; Oliver Bruder Journal: Clin Res Cardiol Date: 2011-02-24 Impact factor: 5.460
Authors: Andreas Rolf; Birgit Assmus; Volker Schächinger; Johannes Rixe; Susanne Möllmann; Helge Möllmann; Stefanie Dimmeler; Andreas M Zeiher; Christian W Hamm; Thorsten Dill Journal: Clin Res Cardiol Date: 2011-06-17 Impact factor: 5.460
Authors: Hans-Josef Feistritzer; Sebastian Johannes Reinstadler; Gert Klug; Martin Reindl; Sebastian Wöhrer; Christoph Brenner; Agnes Mayr; Johannes Mair; Bernhard Metzler Journal: BMC Cardiovasc Disord Date: 2016-11-28 Impact factor: 2.298
Authors: Suzanne de Waha; Ingo Eitel; Steffen Desch; Georg Fuernau; Philipp Lurz; Thomas Stiermaier; Stephan Blazek; Gerhard Schuler; Holger Thiele Journal: Trials Date: 2014-06-25 Impact factor: 2.279